Table 3.
- Allele frequency of the RPL5 genetic polymorphisms in hepatic vein thrombosis (HVT) patients compared with the control subjects.
| db SNP b153 v 2 | Alleles | Patients | Control | P-value* | Unadjusted OR [95% CI] |
|---|---|---|---|---|---|
| rs138979590 | G | 224 (87.3) | 198 (87.6) | Reference | |
| C | 26 (9.1) | 16 (7.1) | 0.350 | 1.44 [0.75-2.76] | |
| T | 36(12.6) | 12(5.3) | 0.006* | 2.65 [1.34-5.24] | |
| rs558220259 | A | 221 (77.3) | 183 (80.9) | 0.362 | Reference |
| G | 65 (22.7) | 43 (19.1) | 1.25 [0.81-1.93] | ||
| rs576892621 | A | 233 (81.5) | 189 (83.6) | 0.603 | Reference |
| G | 53 (18.5) | 37 (16.3) | 1.16 [0.73-1.84] | ||
| rs182018447 | G | 229 (80.1) | 201 (88.9) | 0.009* | Reference |
| A | 57 (19.9) | 25 (11.1) | 2.00 [1.23-3.32] | ||
| rs559377519 | A | 238 (83.2) | 202 (89.4) | 0.032* | Reference |
| T | 48 (16.8) | 24 (10.6) | 1.73 [1.02-2.92] |
Values are presented as number and percentage (%).
*
P-values were calculated by chi-square analyses. differences were statistically significant at p<0.05.
OR: odds ratio, CI: confidence interval. Single-variant association analyses was performed.